Log In
BCIQ
Print this Print this
 

Combretastatin A4P, fosbretabulin (Zybrestat) (CA4P)

  Manage Alerts
Collapse Summary General Information
Company Mateon Therapeutics Inc.
DescriptionA4 prodrug phosphatase-activated tumor vascular targeting agent
Molecular Target Tubulin
Mechanism of ActionMicrotubule depolymerization
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/02/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today